Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System

NCT04279457 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.

NCT NCT04279457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04279457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System
Lead sponsor
CAMC Health System
Phase
Phase 4
Overall status
Recruiting
Start date
February 3, 2020
Completion date
February 3, 2022
Enrollment
1,802 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aki (acute kidney injury) due to trauma